HamburgA second COVID drug target now has inhibitors.
Mac1 strips a molecular tag the immune system attaches to viral proteins — blocking it uncloaks the virus rather than stopping replication.
The compounds show antiviral activity in cell assays — years from being a medicine.
Sources: Nature